Correction to: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsConnective tissue disorders research · Health Systems, Economic Evaluations, Quality of Life
This is a correction to: Francis H Glorieux et al., Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study, Journal of Bone and Mineral Research, Volume 39, Issue 9, September 2024, Pages 1215–1228, https://doi.org/10.1093/jbmr/zjae112
In the version originally published, the x-axis in Figure 1B was misplaced, passing through the value of `4' on the y-axis. The figure has been corrected for clarity.